NASDAQ: ALZN - Alzamend Neuro, Inc.

Yield per half year: -69.7%
Dividend yield: 0.00%
Sector: Healthcare

Current price
0.9952 $
Average price
0 $ -100%

Price based on EPS
3.13 $ +214.44%
0/10

Price based on EPS

Price = Price * (100 - CAGR EPS * Excess Key Rate) / 100
Key Rate = Key rate
Fair price = 3.13 $
Current price = 0.9952 $ (difference = +214.44%)


Data

Discounted Cash Flow (Based EBITDA)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount Ebitda(5) * (1 + Ebitda Yield) / (WACC - Ebitda Yield)
Company Value = ∑ (Future Ebitda / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = -36.31 $
Current price = 0.9952 $ (difference = -3 748.2%)


Data

Discounted Cash Flow (Based FCF)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount FCF(5) * (1 + FCF Yield) / (WACC - FCF Yield) ^ 5
Company Value = ∑ (FCF / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = -31.07 $
Current price = 0.9952 $ (difference = -3 221.59%)


Data

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription